Clinical Trial Update: Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating higher or lower doses of cladribine, cytarabine, and mitoxantrone in medically less fit patients with newly diagnosed acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia of Ambiguous Lineage
• Myeloid Neoplasm

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cladribine (cladribine)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: University of Washington | Conditions: Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-11-01